Form D · Pharmaceuticals

Ionetix Corp

Lansing, MI · CIK 0001672953

Offering snapshot reported Aug 26, 2024 · SEC filing

Reported sold
$0
Offering amount: $15.4M
Investors reported
0
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 9, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 26, 2024Initial$0No comparison0SEC filing
May 6, 2020Amendment$37,288,167$10,457,174vs Dec 21, 201824SEC filing
Dec 21, 2018Initial$26,830,993No comparison22SEC filing
Mar 12, 2018Amendment$23,795,372$12,326,154vs Apr 27, 201646SEC filing
Apr 27, 2016Initial$11,469,218No comparison30SEC filing

Offering details

Securities
Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$8.65M
Finders' fees
$0
Form D file number
021-522432

Source: Form D, filed Aug 26, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Douglas Boothe Director
Carrie Busch Executive
Kevin Cameron Director, Executive
David Eve Executive
Nancy Hargreaves Executive
David Martin Director
Gregory Martin Director
Phun Phieu Executive
Anthony Stagnolia Executive
Michael Tarnock Director
Michael Tarnok Director
Gregory Taxin Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
3130 Sovereign Drive
Lansing, MI, 48911